Search
for
Sort by
Research 61–90 of 1000+
- Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
- Testosterone Treatment in Women – An Overview
- Main Plenary Sessions: Summaries of Papers
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)
- A new target for squamous cell skin cancer?
- Melatonin Receptors and Their Role in Human Diseases
- Hormonal Therapies in Cosmetic Dermatology: Mechanisms, Clinical Applications, and Future Perspectives
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- Updates in Treatment for Androgenetic Alopecia
- Role of insulin, insulin‐like growth factor‐1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- Repurposing of H1-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software
- Sex hormones and related compounds, including hormonal contraceptives
- Intrinsic versus Extrinsic Aging: A Histopathological, Morphometric and Immunohistochemical Study of Estrogen Receptor β and Androgen Receptor
- Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp
- The role of androgen and androgen receptor in skin-related disorders
- The Distribution of Estrogen Receptor β Is Distinct to That of Estrogen Receptor α and the Androgen Receptor in Human Skin and the Pilosebaceous Unit
- Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Androgen receptor CAG repeat length is associated with ovarian reserve but not with ovarian response
- Androgens and androgen receptor action in skin and hair follicles
- Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Spironolactone use and the risk of breast cancer
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Formestane Preferred as Second-Line Therapy in Advanced Breast Cancer